Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Ibuprofen
Bristol Laboratories Limited
M01AE; M01AE01
Ibuprofen
600 milligram(s)
Film-coated tablet
Product subject to prescription which may be renewed (B)
Propionic acid derivatives; ibuprofen
2019-01-25
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT IBUPROFEN BRIL 600 MG FILM-COATED TABLETS ibuprofen READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours - If you get any side effects, talk to your doctor or pharmacist. It includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Ibuprofen Bril is and what is it used for 2. What you need to know before you take Ibuprofen Bril 3. How to take Ibuprofen Bril 4. Possible side effects 5. How to store Ibuprofen Bril 6. Contents of the pack and other information 1. WHAT IBUPROFEN BRIL IS AND WHAT IS IT USED FOR Ibuprofen Bril belong to a group of medicines called NSAID (non-steroidal anti- inflammatory drugs) which work by reducing pain, inflammation and fever. Ibuprofen Bril is used to relieve pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, arthritis of the spine (ankylosing spondylitis), swollen joints, frozen shoulder, bursitis, tendinitis, tenosynovitis, lower back pain, sprains and strains. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE IBUPROFEN BRIL DO NOT TAKE IBUPROFEN BRIL • if you are allergic to ibuprofen or any of the other ingredients of this medicine listed in section 6. • if you have had allergic reactions such as asthma, runny nose, itchy skin rash or swelling of the lips, face, tongue, or throat after you have taken medicines containing acetylsalicylic acid (such as aspirin) or other drugs for pain and inflammation (NSAIDs). • if you have suffered from an ulcer or bleeding in the stomach or small intestine (duodenum)related to previous use of drugs for pain and inflammation (NSAIDs) • if you are suffering from an ulcer or bleeding in Read the complete document
Health Products Regulatory Authority 30 September 2019 CRN008LCN Page 1 of 10 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ibuprofen Bril 600 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 600 mg ibuprofen Excipient with known effect: lactose monohydrate 24 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablets Ibuprofen 600 mg film-coated tablets are white, about 19 mm X 8 mm capsule shaped, film-coated tablets, plain on both sides. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _Symptomatic treatment of_ Symptomatic treatment of pain and inflammation in arthritic diseases (e.g. rheumatoid arthritis), degenerative arthritic conditions (e.g. osteoarthritis), and in painful swelling and inflammation after soft tissue injuries. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral use. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4) The tablet should be swallowed with a whole glass of water during or after a meal. The ibuprofen dose depends on the patient’s age and body weight. _Rheumatic diseases_ Adults: The usualdose is400-600mgthree times daily.In somepatients,maintenance dosesof 600mg-1200 mg per dayare effective. In acute andseverediseasemaybe increased toa maximum of2400 mgin 3 or4doses. Adolescents older than12 years(> 40kg):` The recommendeddose is20mg/kgup to 40 mg/kg bodyweight perday in 3-4doses. Special populations: Paediatric population: Ibuprofen 600 mg film-coated Tablets is contraindicated in children and adolescents younger than 12 years of age due to lack of possibility of correct dosing. Older people NSAIDs should be used with particular caution in elderly patients who are more prone to adverse events and are at increased risk of potentially fatal gastrointestinal haemorrhage, ulceration or perforation (see section 4.4). If treatment is considered necessary, the lowest dose for the sh Read the complete document